Advanced search
Start date
Betweenand

Dengue: production of experimental batches of a tetravalent candidate vaccine against dengue

Grant number: 08/50029-7
Support type:Research Grants - Research Partnership for Technological Innovation - SUS (PITE-SUS)
Duration: June 01, 2008 - November 30, 2011
Field of knowledge:Health Sciences - Collective Health - Public Health
Cooperation agreement: CNPq - PPSUS
Principal Investigator:Isaias Raw
Grantee:Isaias Raw
Home Institution: Instituto Butantan. Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Company: Ministério da Saúde (Brasil). Sistema Único de Saúde (SUS)
City: São Paulo
Partner institutions: Ministério da Saúde (Brasil). Sistema Único de Saúde (SUS)
Matéria(s) publicada(s) na Agência FAPESP sobre o auxílio:
Butantan Institute and MSD agree to collaborate on dengue vaccine development 
Researchers identify bacteria capable of killing <i>Aedes aegypti</i> larvae 
Interactions between Zika and dengue to be studied in trials of Brazilian vaccine 
Brazilian dengue vaccine supported by FAPESP starts Phase 3 clinical trial 
Dengue vaccine could be adapted to combat zika virus 
New evidence may influence Brazil's choice of dengue vaccine 
Dengue vaccine begins final stage of clinical trials 
Approval of dengue vaccine could be advanced by two years  
Brazilian researchers announce clinical trials for dengue vaccine 
Articles published in Pesquisa FAPESP Magazine about the research grant:
A villain with many faces 
A villain with many faces 
Articles published in other media outlets (3 total):
UOL: Segunda etapa dos testes mostrou efeito protetor de vacina contra a dengue (15/Apr/2020)
Biblioteca FMUSP: Vacina liofilizada contra a dengue produzida no Instituto Butantan (11/May/2020)
Blog Infectologia em Geral: Segunda etapa dos testes mostrou efeito protetor de vacina contra a dengue (19/Apr/2020)